Zai Lab Limited
NASDAQ:ZLABBiotechnology
Healthcare
$21.92 +3.42%
+$0.61 today
- Market cap
- $2.47B
- Beta
- 0.78
- P/E (TTM)
- -11.4
- EPS (TTM)
- -$0.16
52W Low $15.96High $41.20
Volume 0.61M
Average 0.87M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$150.79M
FY 2025 · Annual
Investing Cash Flow
$307.87M
FY 2025 · Annual
Financing Cash Flow
$72.35M
FY 2025 · Annual
-79.3% YoYCash Flow Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (704.47M) | (443.29M) | (334.62M) | (257.1M) | (175.54M) |
| Depreciation & Amortization | 6.49M | 8.23M | 9.03M | 11.86M | 15.01M |
| Deferred Income Tax | 17.08M | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 40.71M | 61.3M | 79.63M | 70.65M | 65.6M |
| Change in Working Capital | 23.11M | (66.25M) | 39.61M | (68.39M) | (54.71M) |
| Accounts Receivables | (42.32M) | 25.14M | (17.69M) | (26.58M) | (29.98M) |
| Inventory | (7.17M) | (15.38M) | (14.91M) | 3.9M | (47.03M) |
| Accounts Payables | 63.52M | (53.77M) | 36.8M | (2.21M) | 19.93M |
| Other Working Capital | 9.08M | (22.23M) | 35.4M | (43.5M) | 2.38M |
| Other Non-Cash Items | 67.85M | 72.36M | 8.17M | 28.12M | (1.15M) |
| Operating Cash Flow | (549.23M) | (367.64M) | (198.18M) | (214.87M) | (150.79M) |
| Capital Expenditures | (18.95M) | (24.98M) | (8.49M) | (61.52M) | (13.42M) |
| Acquisitions (Net) | (30M) | 0 | 0 | 29K | 0 |
| Purchases of Investments | (445M) | (260.27M) | (134M) | (330M) | (10M) |
| Sales of Investments | 743.9M | 705.27M | 117.7M | 16.3M | 331.2M |
| Other Investing Activities | 3K | (399K) | 12.74M | (55.86M) | (5.24M) |
| Investing Cash Flow | 249.96M | 420.02M | (10.78M) | (375.19M) | 307.87M |
| Debt Repayment | 0 | 0 | 0 | 131.32M | 67.94M |
| Common Stock Issued | 818.88M | 0 | 0 | 217.35M | 13.68M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 1.33M | (1.73M) | (6.43M) | 1.22M | (9.27M) |
| Financing Cash Flow | 820.2M | (1.73M) | (6.43M) | 349.89M | 72.35M |
| Effect of Forex Changes | 1.12M | (6.27M) | (2.62M) | (310K) | 478K |
| Net Change in Cash | 522.04M | 44.37M | (218.01M) | (240.48M) | 229.91M |
| Free Cash Flow | (568.18M) | (392.63M) | (206.67M) | (276.39M) | (164.21M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$175.5M
+ D&A$15.0M
+ Stock-Based Comp$65.6M
+ Deferred Tax$0
- Working Capital-$54.7M
- Other Non-Cash-$1.2M
= Operating Cash Flow-$150.8M
- Capex-$13.4M
= Free Cash Flow-$164.2M
Analysis
FY2025 free cash flow is -$164.2M. FCF conversion is 93.5% of net income. Operating cash flow was -$150.8M, with capex of -$13.4M. The largest bridge item is Stock-Based Comp at $65.6M.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | Nov 13, 2026 | |
| D | D filing | Nov 9, 2026 | |
| 8-K | Current report | Nov 5, 2026 | |
| 10-Q | Quarterly report | Nov 5, 2026 | |
| 8-K | Current report | Oct 23, 2026 |
Does ZLAB generate free cash flow?
Zai Lab Limited (ZLAB) generated -$164.21M of free cash flow in fiscal 2025.
How much operating cash flow does ZLAB produce?
Operating cash flow was -$150.79M, before capital expenditures of $13.42M.
Continue the stock analysis
Jump to another research area for this company.